Discovery and selection of TMC114, a next generation HIV-1 protease inhibitor
Surleraux, D.L.N.G., Tahri, A., Verschueren, W.G., Pille, G.M.E., de Kock, H.A., Jonckers, T.H.M., Peeters, A., De Meyer, S., Azijn, H., Pauwels, R., de Bethune, M.-P., King, N.M., Prabu-Jeyabalan, M., Schiffer, C.A., Wigerinck, P.B.T.P.(2005) J Med Chem 48: 1813-1822
- PubMed: 15771427 
- DOI: 10.1021/jm049560p
- Primary Citation of Related Structures:  
1T3R, 1T7I, 1T7J - PubMed Abstract: 
The screening of known HIV-1 protease inhibitors against a panel of multi-drug-resistant viruses revealed the potent activity of TMC126 on drug-resistant mutants. In comparison to amprenavir, the improved affinity of TMC126 is largely the result of one extra hydrogen bond to the backbone of the protein in the P2 pocket ...